



parasites in their blood film, 97
(36.5%) were blood culture
positive, and 12 (4.5%) had both
positive blood culture and malaria
parasite. Among the recruited
babies, 82.4% were noticed to have
low parasite density, 13.2% had
moderate density, while 2.6% had
high density. Peripartum pyrexia,
prematurity and intrauterine HIV
exposure, were found to have
significant association with
congenital malaria, (OR = 7.9, 7.2,
4.4) for peripatum pyrexia,
prematurity and HIV exposure, p
values <0.05. None of the clinical
feature had good sensitivity,
specificity or predictive value for
congenital malaria, and only 1.6%
death was recorded in a baby with
high parasite density.
Congenital malaria is
common in newborns with
suspected neonatal sepsis. History
of peripartum pyrexia, prematurity
and intrauterine HIV exposure was
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of congenital malaria do not differ
much from those of neonatal
sepsis: both can co-exist, and most
times very difficult to differentiate
clinically.
To document the
prevalence, risk factors for
congeni ta l malar ia among
neonates admitted for suspected
neonatal sepsis, and determine
sensit ivity, specifici ty and
predictive values of some common
signs and symptoms.
Blood for culture, thin
and thick blood film for malaria
parasite were taken for all cases of
suspected neonatal sepsis at the
special care baby unit of the
hospital, from August 2007 to
December 2009
A total of 266 newborns
(150 males and 116 females) with
suspected neonatal sepsis were
recruited. Their mean admission
w e igh t w as 2 .5±0 .87 kg ,
gestational age was 36.1±3.5
weeks, and age of 5.1±2.3 days.
While 76 (28.6%) had malaria
Introduction
Neonatal sepsis (NS) has remained one of the
commonest reason for admission into most special
care baby unit (SCBU) in Nigeria. It is responsible
for over 25% of all neonatal mortality, and a major
problem in many developing countries partly
because of non-availability of standard neonatal
care. Malaria has also been recognized as a leading
1
2,3
cause of infant morbidity and mortality in African
but neonatal malaria (NM) was taught to be rare.
This was believed to be partly due to the protective
effect of fetal haemoglobin F present in the blood of
the neonates, as well as the transplacental transferred
maternal antibodies. Congenital malaria (CM) is
defined as the presence of malaria parasite (MP) in
the peripheral blood smear of a new born baby within
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maternity homes, nearby primary health centers in
addition to self referrals from home. SCBU is a 32-
bed capacity key service ward in our health
institution. It is an area where newborns are promptly
managed on 24 hour basis, and represents a high
volume, high stress service area of the hospital.
UATH is a 350-bed capacity tertiary health institution
located in the Federal Capital Territory (FCT), Abuja
in the north central zone of the country. It is sub-
serving many neighbouring states including
Nassarawa, Niger, Kogi, Benue, parts of Kaduna
state and FCT,Abuja
Blood for culture, total white blood cell count/
differentials, and malaria parasite (MP) were
collected from the study patients. Blood for culture
was collected in 2 bottles, one containing glucose
broth and the other thio-glycolate medium, and both
were incubated at 37°C for 48 hours. Growth in either
of the media was sub-cultured on Mc-Conkey, blood
or chocolate agar and further tested for antibiotic
sensitivity. However, if no growth was observed,
further incubation was done for another 48 hours.
Other investigations like urine, stool or cerebrospinal
fluid culture were determined by clinical
presentations of the neonate. Thin and thick blood
films were prepared immediately upon collection of
blood on separate slide. For thick films, 12 µl of blood
was spread over a diameter of about 15 mm, while 2
µl of blood was used for thin films. The thick film
smear was allowed to air dry before being
dehaemoglobinized with buffered distilled water at
PH of 7.2. The thin film was fixed in absolute
methanol for 1-2 minute before air drying. Both thick
and thin blood films were stained after 24-48 hr with
3% Giemsa stain solution at pH 7.2. For the thick film
the dilution was in the ratio of 1 volume of Giemsa to
9 volume of buffered distilled water, while that of thin
film the dilution was at 1 : 29 of Giemsa and distilled
water. The stained slides were read by a Laboratory
Technologist. The method adopted by Greenwood
andArmstrong and described by Cheesbrough was
used to determine MPdensity. The average number of
parasites counted per high power field (100 x
objectives) was multiplied by 500.
sh chromatin dot with
a purple or blue cytoplasm of the malaria parasites are
seen together. A slide was pronounced negative when
100 high power fields have been examined using
×100 oil immersion objective lens. Malaria parasite
density was considered significant when MP count
was greater than 1,000 parasit
tained, moderate count was a
count of >500-<1,500 parasite/µl of blood, while






and 15 fields were counted for each slide, and results
given per μl of blood. A definitive diagnosis of
malaria was made when a reddi
per μl of blood. Low
parasite count was when count of 500 parasite/µ/ of
blood and below was ob
reported cases of CM in most endemic malaria areas,
ranging from 1.5% in Maputo Mozambique, to
28.2% in Jos, Nigeria 35% in Calabar and as high
as 46.7% in Ile-Ife. The reported increase has been
attributed to increased resistance of
(PF) to anti-malaria drugs resulting in
increase in maternal parasitaemia, mothers on
regular malaria chemoprophylaxis having low
malaria antibody titers and hence transfer little
protective antibody to their newborns, and most
importantly increased reporting of cases. CM is
thought to have resulted from MP crossing the
placenta from maternal blood to the fetal circulation.
The exact mechanism of this crossing is not know,
but damage to the syncytiotrophoblast occurring
during active placental infection has been
suggested. This type of malaria has been shown to
occur in babies of clinically healthy mothers who are
delivered in malaria endemic areas. In babies of
these women with high level of immunity, CM is
generally asymptomatic, majority of parasites being
rapidly cleared from the infant's circulation as a
result of passive protection of the baby by maternal
antibody crossing the placenta, active immunity
developing from exposure to soluble malaria
antigens in utero, and high proportion of fetal
haemoglobin present in the babies which retards the
growth of the parasite.
Clinical signs of CM may be indistinguishable from
that of NS. This has lead to many researchers
suggested screening for MP to be included as part of
routine investigation in newborn infants with fever.
The increasing reported cases of CM in
hyperendemic areas, and the difficulty in
differentiating NS from this disease condition
necessitated the need to determine the prevalence of
CM in babies admitted for NS, assess the risk factors
associated with it and determine sensitivity,
specificity, and positive predictive values of some
common clinical signs and symptoms. It is
envisaged that the result(s) of this findings will assist
health care providers in identifying newborns at risk
of this disease for early investigation and
management.
An 18month prospective study was carried out at
University of Abuja Teaching Hospital (UATH),
Gwagwalada between the months of August 2007 to
December 2009. Neonates with features of NS and
admitted into the special care baby unit (SCBU) of
the hospital were recruited into the study. For the
purpose this study, analysis was on newborns with
congenital malaria (ie those babies with positive MP
in their blood stream in their first seven days of life).
Majority of the babies admitted into the unit were
referrals from the neighbouring general, private, and

















Table: 3 shows maternal and neonatal factors and
malaria parasite density among 64 newborns with
CM. Congenital malaria was identified in 71.9% of
neonates from low socio-economic class (LSEC), in
67.2% of mothers on anti malaria prophylaxis
(daraprim) during pregnancy, in 65.6% of preterm
deliveries, in 59.4% of para1 and 2 mothers, and in
39.1% of mothers with peri-partum pyrexia (PPP).
Low birth weight (LBW), maternal PPP, and intra
uterine HIV exposure, were the maternal and
neonatal factors found to have significant association
with CM (OR of 7.2 with CI of 1.20 18.47, p value
0.002 for LBW, OR of 7.6 with CI of 1.32 18.37, p
value 0.002 for PPP, OR of 4.4, 95% CI of 0.98 -9.82
and p value 0.35 for HIV exposure. No association
was seen in mothers with rupture of membrane (OR
of 0.66, 95% CI of 0.19 - 2.14, p value 0.55), and
those on anti malaria prophylaxis (OR of 0.33, 95%
CI 0.12 - 2.01, p value 0.65). Moderate and high
parasitaemia were seen more in newborns of mothers
with PPP, preterm deliveries, HIV exposed babies of
mothers from low socio-economic class (LSEC).
Sensitivity, Specificity and Positive Predictive
Values of Common Presenting Signs and Symptoms
Sensitivity, specificity and positive predictive values
(PPV) of common clinical signs and symptoms of
CM in newborns was shown in table 4. While
hepatomegaly, fever, jaundice, fast breathing, poor
feeding, pallor, and irritability were the common
symptoms and signs seen in newborns with CM,
jaundice, pallor, fever, and hepatomegaly were the
only three clinical features that had fairly good
sensitivity, specificity with PPV, 81.3%, 34.2% and
28.1% for hepatomegaly, 50.0%, 43.5%, and 21.9%
for fever, 39.0%, 67.8% and 38.5% for jaundice, and
23.4%, 83.7% and 31.3% for pallor.
Table 1
Profile of Recruited Newborns with Presumed
Sepsis.
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Other information collected from the patients
includes: age at onset of symptoms (days),
presenting problem and duration of such problem,
gender, admission weight (AW), mother's parity,
history of maternal peri-partum pyrexia (PPP),
history of rupture of membrane (ROM), whether the
mother attended/ received antenatal care, gestational
age (GA), treatment given/ outcome of the illness,
HIV status of the mother, and socio-economic status
(SES) of the parents using Olusanya's two factor
index: husband's occupation and mother's level of
education. All newborns admitted into SCBU for
CM and found to have moderate and high MPdensity
in their blood film were treated for malaria with oral
quinine.
Ethical approval was obtained from the Ethics
committee of the hospital. Signed or thumb-printed
informed consent was also obtained from the
mothers of the subjects after adequate explanation of
the purpose of the research in the language they
understood best. The research data was coded,
privacy protected and confidentiality maintained.
Data analysis was conducted using SPSS version
13.5. Tests for associations and differences were
done by chi-square analysis. Statistical significance
was set at value < 0.05.
The characteristics of recruited newborns are shown
in table 1.Atotal of 266 newborns with suspected NS
and accounting for 25.8% of the total admissions
were recruited for the study. There were 150 males
and 116 females with male to female ratio of 1.3:1.
The mean admission weight( AW) was 2.5±0.87 kg,
with mean GAof 36.1±3.5 weeks, and age of 5.1±2.3
days.
Babies with Malaria Parasitaemia
A total of 76 neonates (35 males and 41 females: 0.9
to 1) were positive for malaria parasitaemia (MP)
while 109 had culture-proven sepsis accounting for
26.8% and 41.0% of the screened population
respectively. Of these, 64 had MP alone, 97 had
bacterial sepsis alone and 12 had MP in association
with culture proven sepsis. The meanAW for babies
with CM was 2.4±0.24 kg, GAof 35±4.3 weeks and
Age of 3±0.7 days. Further analysis of babies with
CM showed that 52 (81.3%) of them had low PD
(parasite count of 500 parasite/µ/ of blood), 10
(15.6%) had moderate PD (parasite count of >500-
<1,500 parasite/µl of blood), while 2 (3.1%) had
high PD (parasite count of > 1,500-> 3,000
parasite/µl) fig 1. There was no significant
difference in malaria PD between male and female
newborns, p >0.05 (table: 2).



































*Values are mean ±SD
SVD = Spontaneous vertex delivery.




Malaria Parasite Density in Babies Admitted For
Neonatal Sepsis according to sex.
MP= Malaria Parasite, CM= Congenital Malaria,
PD= Parasite Density, BCP= Blood culture positive.
Low= 500 parasite/µ/ of blood.
Moderate=>500- <1,500 parasite/µl of blood.
High=> 1,500-> 3,000 parasite/µl.
Figure 1: Malaria parasite densiy distribution among
76 neonates with congenital malaria
Low= 500 parasite/µ/ of blood
Moderate=>500- <1,500 parasite/µl of blood




No of recruited patients 150(56.4) 116(43.6) 266(100)
Total no with CM 36(47.4) 40(52.6) 76(28.6)
No with only CM 30(46.9) 34(53.1) 64(24.1)
Only CM with low PD 23(44.2) 29(55.8) 52(81.3)
Only CM with moderate PD 3(30.0) 7(70.0) 10(15.6)
Only CM with high PD 2(100.0) 0(0.0) 2(3.1)
No of BCP patients 61(62.9) 36(37.1) 97(36.5)
No of BCP with CM 8(66.6) 4(33.3) 12(12.4)
CM with Low PD and BCP 7(77.7) 2(22.2) 9(75.0)
CM with moderate PD and BCP 1(33.3) 2(66.6) 3(25.0)





High (%) Total (%)
Peripartum pyrexia 14(56.0) 10(40.0) 1(4.0) 25(30.1)
Rupture of membrane 6(66.7) 33(33.3) 0(0.0) 9(14.1)
Para1 17(77.3) 5(22.7) 0(0.0) 22(34.4)
Para 2 13(1.3) 3(18.8) 0(0.0) 16(25.0)
Para 3 12(80.0) 1(6.7) 2(13.3) 15(23.4)
Para >3 10(0.9) 1(9.1) 0(0.0) 11(17.2)
Birth weight <2,500gms 31(73.8) 9(21.4) 2(4.8) 42(65.6)
Birth weight > 2,500gms 21(95.5) 1(4.5) 0(0.0) 22(34.4)
HIV exposed babies 6(50.0) 4(33.3) 2(16.7) 12(18.8)
Mothers on AM prophylaxis during pregnancy 41(95.3) 2(4.7) 0)0.0) 43(67.2)
SES 1 3(75.0) 1(25.0) 0(0.0) 4(6.3)
SES 11 5(100.0) 0(0.0) 0(0.0) 5(7.8)
SES 111 8(88.9) 1(11.1) 0(0.0) 9(14.1)
SES 1V 16(76.2) 4(19.1) 1(4.8) 21(32.8)
SES V 20(80.0) 4(16.0) 1(4.0) 25(39.1)
Table: 3 Maternal/Neonatal factors and Malaria Parasite Density in 64 Newborns with Congenital
Malaria only.
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reported prevalence rates of CM in different parts of
the country and even in the same geographical zones
may be attributed to the skill and experience of the
laboratory personnel involved in blood film
preparation, staining, and reading of the slides, as
results of training programmes on malaria
microscopy have shown low levels of sensitivity and
specificity of those involved in malaria diagnosis
routinely and for research, or it could be as a result
of increased resistance of
(PF) to anti-malaria drugs in some parts of the
country resulting in increase in maternal
parasitaemia. However, all these reports support the





Low= 500 parasite/µ/ of blood
Moderate=>500- <1,500 parasite/µl of blood
High=> 1,500-> 3,000 parasite/µl
SES- Socio-economic class.
Low=500 parasite/µ/ of blood and below
Moderate= >500- <1,500 parasite/µl of blood
High= >1,500- >3,000 parasite/µl
The data generated from the study shows that CM is
common in newborns with suspected NS (28.6%).
This was similar to 35.0% from a similar study in
Calabar and 28.2% from another study in
hyperendemic area of Jos in the same geographical
zone. The finding was however higher than 5.1%
reported in a multi-center study in the country,
8.25% from Northern part of the country, and
16.7% from Tanzania, but much lower than 46.7%









Frequency of selected maternal and neonatal factors among 64
neonates who had congenital malaria only.
Maternal/Neonatal factors Low Moderate High Total (%)
Peripartum pyrexia 14 10 1 25(39.1)
Rupture of membrane 6 33 0 9(14.1)
Para1 17 5 0 22(34.4)
Para 2 13 3 0 16(25.0)
Para 3 12 1 2 15(23.4)
Para >3 10 1 0 11(17.2)
Birth weight <2,500gms 31 9 2 42(65.6)
Birth weight > 2,500gms 21 1 0 22(34.4)
HIV exposed babies 6 4 2 12(18.8)
Mothers on AM prophylaxis during pregnancy 41 2 0 43(67.2)
SES 1 3 1 0 4(6.3)
SES 11 5 0 0 5(7.8)
SES 111 8 1 0 9(14.1)
SES 1V 16 4 1 21(32.8)
SES V 20 4 1 25(39.1)















Fever 20(62.5) 10(31.3) 2(6.3) 32(50.0) 50.0 43.5 21.9
Diarrhoea 3(75.0) 1(25.0) 0(0.0) 4(6.2) 6.3 89.6 16.0
Jaundice 19(76.0) 4(16.0) 2(8.0) 25(39.0) 39.0 67.8 38.5
Irritability 2(15.4) 9(69.2) 2(15.4) 13(20.3) 20.3 57.4 13.3
Pallor 6(40.0) 7(46.7) 2(13.3) 15(24.3) 23.4 83.7 31.3
Fast breathing 10(50.0) 8(40.0) 2(10.0) 20(31.3) 39.0 32.2 15.4
Poor feeding 12(70.6) 5(29.4) 2(11.8) 17(26.6) 26.6 24.8 10.1
Hepatomegaly 20(62.5) 10(31.3) 2(6.3) 32(50.0) 81.3 34.2 28.1
Table 5:Clinical Signs and Symptoms and Malaria Parasite Density in 64 Neonates
with Only Congenital Malaria.
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between malaria parasite and low birth weight, as
placental parasitaemia has been reported as a major
cause of LBW in malaria endemic areas. Maternal
HIV infection has also been found to increases the
prevalence and intensity of malaria infections in
pregnancy. Both HIV infection and malaria in the
mother are well known independent risk factors for
both the mother and her baby, and when both co-
exist, the risk of damage to the placental
syncytiotrophoblast will be increased so also will be
there be more chances of entry of MP into the feotal
circulation, and hence CM.
Clinical signs of CM may be indistinguishable from
those of NS whose main presentation is fever, this has
led to the suggestion that screening for MP should be
included as part of routine investigation in newborn
infants with fever, as Nyirjesy et al has reported
increased risk of perinatal deaths (RR=7.2), and low
birth weight from CM. In the present study, most
blood culture positive neonates and those with
moderate and high density parasitaemia in their
blood smear presented with fever, thus justifying the
recommendation that all newborns with fever should
be screened for malaria. There is wide documented
similarity in the clinical presentation of these two
disease entities and because of the difficulties
encountered clinically in differentiating the two
especially in hyperendemic malaria areas, the
sensitivity, specificity as well as the PPV of common
clinical signs and symptoms tested. Though none of
the clinical signs and symptoms showed good
sensitivity/ specificity and PPV for CM, however,
fever, hepatomegaly, jaundice and pallor had fairly
varying sensitivity, specificity and PPV for CM. The
present study therefore justifies the recommendation
that screening for MP be part of septic work up in
newborns who presented with fever, especially when
there is an associated history of maternal PPP,
prematurity or intrauterine HIV exposure.
33
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Early workers found primary attack of CM to be mild,
and in most instances confined to a transient
asymptomatic parasitaemia. In the majority of
asymptomatic cases, the parasites were rapidly
cleared from the infant's blood from the
transplacentally transferred maternal antibodies.
In support of above statement was the findings that
62.1% of smear positive newborns had remained
asymptomatic after three days of delivery in a multi-
centered study in the country. In the present study,
81.3% of newborns with CM had low parasite count
of 500 parasite/µ/l of blood or less, thus this may
represent the transient asymptomatic parasitaemia
phase that may be cleared off with time. Only 18.7%
presented with moderate and high malaria PD of
>500 parasite/µ/l of blood which could be the
s y m p t o m a t i c f o r m o f C M .
Many risk factors have been identified to increase the
risk of CM in newborns, notably among them
includes primigravidae, LBW and PPP. Similar risk
factors including intrauterine HIV exposure were
also found to have increased association with CM
(OR = 4.4) in the present study. Peripartum pyrexia
which results from maternal infective conditions
notably malaria may damage the syncytiotrophoblast
during active placental infection. This damage as
previously documented will facilitate the entry of MP
from the placenta into the fetal circulation, thus
increasing the chances of CM in her offspring.
Primigravidas have also been reported to be at a
Greatest risk of malaria in pregnancy because they
lack the specific immunity to placental malaria which
is acquired from exposure to malaria parasites during
pregnancy. This immunity accumulates with
successive pregnancies, provided there is exposure to
malaria infection.
Literature exist between maternal/placental malaria
parasitaemia during pregnancy and LBW. It is
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